Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|20|4790-4805

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.20, 2015-10, pp. : 4790-4805

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 565-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of new lead pyrimidines derivatives as potential cannabinoid CB1 receptor antagonistic through molecular modeling and pharmacophore approach

By Sharma Mukesh  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2287-2311

Springer Publishing Company

Access to resources Recommend Favorite

A2A–CB1 receptor interaction in corticostriatal terminals

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1074-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cannabinoid CB1 receptors mediate the effects of dipyrone

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 3, 2015-03 ,pp. : 246-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 22, 2015-11 ,pp. : 5333-5346

John Wiley & Sons Inc

Access to resources Recommend Favorite